This program is intended to address the limited availability of adjuvants that mimic those with a favorable clinical track record or show high potential in late pre-clinical testing.

The following institutions were awarded:

Emory University, Atlanta, GA 

Principal investigators: Neel Gandhi, MD; Jyothi Rengarajan, PhD

Grant: P30AI168386

In 2022, NIAID established six new Tuberculosis Research Advancement Centers (TRACs) to foster multidisciplinary tuberculosis (TB) research and deliver exceptional mentorship to new investigators.

The newly established TRACs will provide scientific leadership and institutional infrastructure dedicated to TB research and will foster and enhance multidisciplinary collaboration. The Centers are dedicated to developing the next generation of scientific leaders in TB research through mentoring and training opportunities and by providing funding support for either new investigators pursuing TB research or researchers who want to enter the TB field at institutions within the TRAC network. The TRACs will provide shared research support for resources, services and training dedicated to TB, and will strengthen TB clinical research through international and/or domestic collaborations.

The purpose of this Notice of Funding Opportunity (NOFO) is to provide early-stage investigators with support and protected time (up to five years) for intensive, research-focused career development program activities under the guidance of an experienced mentorship team with expertise in both the preclinical application of nonhuman primate (NHP) models and in translation of the results from such studies to clinical application.

The purpose of the NIAID Physician-Scientist Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented independent physician-scientists. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions.

The purpose of the NIAID Physician-Scientist Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented independent physician-scientists. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions.

Priorities for research in leprosy today include genetic probes for molecular epidemiology, and new immunologic tests for early detection of leprosy before nerve damage occurs. The goals are to provide evidence on routes of transmission and incubation periods and to develop new tools to prevent and, ultimately, eradicate leprosy.

Researchers are exploring vaccines to prevent Shiga Toxin-Producing E. coli (STEC) in animals and humans.